Slickly designed websites. Unbelievable markdowns. A simple online search for semaglutide, the active ingredient in Ozempic or Wegovy, can lead consumers down a rabbit hole of seemingly reputable ...

Novo Nordisk's sales of blockbuster obesity drug Wegovy grew by a massive 79% in the third quarter, in a relief to investors after disappointing results three months ago. GLP-1 agonist Wegovy ...

The U.S. Food and Drug Administration has added a new warning to drugs including Ozempic and Wegovy, cautioning that patients taking the drugs may be at a higher risk of inhaling gastric contents ...

Novo Nordisk, the maker of Ozempic, reported that compounded versions of semaglutide, the main ingredient in Ozempic and Wegovy, have led to at least 100 hospitalizations and 10 deaths.

The national use of weight loss drugs like Ozempic and Wegovy more than doubled as bariatric surgery frequency dropped by about 25 percent from 2022 to 2023, researchers report in an Oct. 25 study ...

Weight loss jabs could be 'game-changers' in tackling common cancer, claim doctors Credit: Getty Professors Tim Spector and Sarah Berry of King’s College London are now heading a five-year £ ...

Other side effects include 7,228 reports of nausea, vomiting, and diarrhoea linked to the use of weight loss jabs such as Wegovy and Ozempic. Out of the patients who reported the above side ...

Please verify your email address.

Within Novo Nordisk's comprehensive business update to investors, attention latched onto early data for an oral obesity therapy that outperformed the company’s big-selling GLP-1 agonist Wegovy ...